AQR CAPITAL MANAGEMENT LLC 13D/13G Filings for Haemonetics Corporation (HAE)

AQR CAPITAL MANAGEMENT LLC 13D and 13G filings for Haemonetics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-13
10:10 am
Purchase
2025-12-3113GHaemonetics Corporation
HAE
AQR CAPITAL MANAGEMENT LLC3,163,104
6.760%
3,163,104increase
(New Position)
Filing